Tumor protein vaccine prophylactic trials are designed to examine whether the vaccine's targets are directed against a wide range of antigens, can cover 90% or even 100% of patients with different tumor subtypes as well as whether they can boost the body's immune system before tumors form.

For more product details, please visit Aladdin Scientific website.

https://www.aladdinsci.com/